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(Background)The objective of this study was to assess the impact of chronic atrial fibrillation (CAF) on the long-term outcome after percutaneous 
mitral balloon valvuloplaty (PMV).
(Method and Results) We analysed clinical follow-up data (median 62 months) of 84 consecutive patients (age 62±9 years) who were underwent 
PMV between 2000 and 2009. Seventy-seven (91%) patients achieved procedural success, defined as mitral valve area (MVA) >1.5cm2 and mitral 
regurgitation <2/4. They were divided into two groups depending on whether they had sinus rhythm (SR) (N=24) or CAF (N=53). Baseline clinical and 
echocardiographic characteristics were not significantly different. However, the values of left atrial size, baseline NYHA class, post procedural NYHA 
class and Wilkins score of CAF group were higher than those of SR group. Death, admission for heart failure, mitral valve surgery, repeat PMV, and 
major embolic event were included as clinical event. The 9 year rates of total survival and event-free survival were 86±11% and 38±8%,respectively. 
The table demonstrated CAF group showed significantly lower event-free rate than SR group. (P=0.01) CAF was an independent predictor of clinical 
events in the Cox proportional hazard models ajusted for the age, sex, NYHA class. (95%CI=1.1-10.6 p=0.039)
(Conclusions) PMV is a safe and useful palliative procedure with an excellent long term result. Patients with CAF is significantly associated with 
less symptomatic relief and higher event rate post PMV a
